Skip to content
Screener

Price / earnings at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
14.8×
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
178.1×
Bioventus logo
BioventusBVS
11.7×
Organon logo
OrganonOGN
5.5×+1.8×
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
27.5×-252×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
11.4×-5.5×

Other financials

Income statement

See full
Revenue$199.9M+6.3%
Gross profit$110.3M+1.8%
Operating income$3.7M-89.5%
Net income-$15.1M-226%
EPS (diluted)-$0.46-235%

Balance sheet

See full
Cash & equivalents$150.4M+8.8%
Total debt$5.0M-19.8%
Total equity$311.9M+34.3%
Total assets$2.1B+34.1%

Cash flow

See full
Operating cash flow$71.3M-1.5%
CapEx$496.0K+663%
Free cash flow$70.8M-2.1%

Valuation

See full
Market cap$944.15M-1.3%
Enterprise value$798.74M-3.1%
P/S1.2×-0.2×

Profitability

See full
Gross margin60%+3.3pp
Operating margin19.5%+1.1pp
Net margin5.9%+0.8pp
FCF margin40.6%+10.8pp

Returns & leverage

See full
Return on equity17.6%+1.4pp
Debt / equity0.0×
Current ratio-0.2×

Where this comes from

Calculated from Collegium Pharmaceutical, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 7:34 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053851

FAQ

What is Collegium Pharmaceutical, Inc.'s price / earnings?
Collegium Pharmaceutical, Inc. (COLL) reported price / earnings of 24.5× in Q2 2026.
How has Collegium Pharmaceutical, Inc.'s price / earnings changed year-over-year?
Collegium Pharmaceutical, Inc.'s price / earnings decreased by 8.2% year-over-year, from 26.7× to 24.5×.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s price / earnings?
Over 4 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s price / earnings has grown at a -2.6% compound annual growth rate (CAGR), from 25.9× to 23.3×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about Collegium Pharmaceutical, Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude